PURE Bioscience

About:

PURE Bioscience develops and markets technology-based bioscience products that provide non-toxic solutions to global health challenges.

Website: http://purebio.com

Top Investors: Tom Lee

Description:

PURE Bioscience develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges. The company is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. They also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Its proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. It was founded in El Cajon, California by Michael L. Krall in 1992.

Total Funding Amount:

$8.57M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

El Cajon, California, United States

Founded Date:

1992-01-01

Contact Email:

info(AT)purebio.com

Founders:

Michael L. Krall

Number of Employees:

11-50

Last Funding Date:

2018-07-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai